Editor’s note: On September 21, 2022, both Guerbet and Bracco Diagnostics released news detailing the FDA approval of a ...
Contrast Media
Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.
September 21, 2022 – Guerbet, a global medical imaging company, has announced that the U.S. Food and Drug Administration ...
“Zero-COVID” policies have had a massive impact around the world. One consequence has been the recent global shortage in ...
In a busy hospital imaging department, maintaining high device uptime levels is critical. If an injector malfunctions or ...
The theme “Everyday progress” seems appropriate for the imaging community in 2022. What a year it’s been. Supply ...
August 3, 2022 — According to an open-access article in ARRS’ American Journal of Roentgenology (AJR), electronic health ...
August 2, 2022 – A new update has been announced as the radiology world continues to address supply disruptions of ...
When it comes to listing needs, patient safety ranks at the top. Just ask an imaging administrator. “There is no way we ...
July 18, 2022 — Fresenius Kabi announced today it will introduce a portfolio of generic contrast media agents in the ...
A patient’s chance of recovery can be directly impacted when a diagnosis is missed or delayed. To get the right ...
July 5, 2022 — In April 2022, a shutdown of Shanghai due to China’s “zero COVID” policy caused a global shortage of ...
The global rise in chronic disease has significantly increased demand for diagnostic imaging procedures, and in turn ...
Here is what you and your colleagues found to be most interesting in the field of medical imaging during the month of ...
June 23, 2022 — Supply chain disruptions have created critical shortages of Omnipaque (iohexol) and Visipaque (iodixanol ...
June 2, 2022 — Today, GE Healthcare issued a statement that it expects production capacity from its Shanghai facility to ...
Patient safety and operational efficiency are behind the development of modern contrast media, selection and utilization ...
Here is what you and your colleagues found to be most interesting in the field of medical imaging during the month of ...
June 1, 2022 — The current shortage of iodinated contrast in the United States due to the COVID-19 related production ...
May 31, 2022 — Imaging Biometrics, LLC (IB), a subsidiary of IQ-AI Limited, announced it has submitted an FDA 510(k) ...
May 19 2022 — Recent disruptions in a pharmaceutical supply chain have impacted the global availability of GE Healthcare ...
May 18, 2022 —According to ARRS’ American Journal of Roentgenology (AJR), to ensure that patients with emergent or life ...
May 13, 2022 — The ACR Committee on Drugs and Contrast Media, within the ACR Commission on Quality and Safety, is aware ...
The global contrast media market is projected to reach $5.9 billion by 2026 from $4.9 billion in 2021, at a CAGR of 3.7% ...
Product Indications and Use: CLARISCAN (gadoterate meglumine) is a gadolinium-based contrast agent indicated for ...